- Consultant physician specializing in clinical trials
- MBA from The Wharton School
- Extensive experience accelerating patient accrual into trials that are lagging their enrollment goals
- Specialty is accelerating enrollment into phase 3 clinical trials, with a frequent focus on “rescue” assignments – turning around trials that have gone “off track”
- Frequently functions as medical monitor, most recently for phase 2 and 3 HCV trials with Sovaldi and Harvoni
- On occasion has worked on writing assignments, NDA development, and preparation for FDA advisory committee
- Has extensive experience working in medical affairs/supporting marketing and sales, including development of training programs and several new product launches
- Clients have included large pharmaceutical corporations such as Gilead, Pfizer, Hoffman La Roche, Schering Plough and Merck; medium-sized companies such as Allergan, Boehringer-Ingelheim and Medimmune; and small companies such as Chiron, MPEX and Intermune
- Therapeutic areas covered have included HCV, HBV, HIV, infectious disease, fungal disease, vaccines, oncology, cardiovascular, respiratory
Education
- MBA in Health Care Management: The Wharton School of Business
- MD: University of the Witwatersrand in Johannesburg